Table 1.
General characteristics of study participants (n = 121).
Table 2.
Internal consistency and reliability measures of the FAB-E scores among PD patients (n = 67).
Table 3.
Concurrent validity using Spearman correlations between the performance on the FAB-E and the other neuropsychological tests among Parkinson’ disease patients (n = 67).
Table 4.
Comparison of the performance of the FAB-E scores between control group and Parkinson’s disease patients (n = 121).
Table 5.
Comparison of the performance of the FAB-E scores between Parkinson’s disease patients with and without cognitive impairment, and with and without dementia (n = 67).
Fig 1.
Discriminant power of the FAB-E among healthy subjects and Parkinson’s disease patients.
Abbreviations: Se, sensitivity; Sp, specificity; AUC, area under the curve.
Fig 2.
Discriminant power of the FAB-E among Parkinson’s disease patients with (MMSE<26) and without (MMSE≥26) cognitive impairment.
Abbreviations: Se, sensitivity; Sp, specificity; AUC, area under the curve.
Fig 3.
Discriminant power of the FAB-E among Parkinson’s disease patients with (MMSE<24) and without (MMSE≥24) dementia.
Abbreviations: Se, sensitivity; Sp, specificity; AUC, area under the curve.
Table 6.
Subgroup analysis of the discriminant power of the FAB-E to detect executive dysfunction between healthy controls and PD patients and between PD patients with (PD-CI) and without cognitive deficits (PD-nonCI) by sociodemographic characteristics.